Table 3. Summary of the 11 healthy adults with invasive pneumococcal disease who died.
Patient | Sex/Age (yr) | Alcoholabuse | Current smoking | Clinical syndrome | Source of isolate | Shock at presentation | Antibiotic therapy | Days to death | Serotype |
1 | M/52 | Yes | Yes | Endocarditis/Meningitis | blood | No | CTX | 29 | 10A |
2 | M/42 | Yes | Yes | Endocarditis | blood | Yes | CRO | 16 | 4 |
3 | M/19 | No | Yes | Pneumonia | blood | Yes | CRO | 9 | 3 |
4 | F/53 | No | No | Pneumonia | blood | No | CRO+LEVO | 30 | 14 |
5 | F/58 | No | No | Pneumonia | blood | Yes | CRO | 29 | 7F |
6 | M/49 | Yes | No | Pneumonia | blood | No | LEVO | 10 | 14 |
7 | M/36 | No | No | Sepsis | blood | Yes | CRO | 1 | 6A |
8 | F/40 | No | Yes | Pneumonia | blood | Yes | CRO | 12 | 7F |
9 | M/37 | No | No | Meningitis | Blood/CSF | No | VAN+RIFA | 4 | 3 |
10 | M/39 | No | Yes | Sepsis | blood | Yes | CTX | 1 | ND |
11 | M/59 | No | Yes | Meningitis | Blood/CSF | Yes | CTX | 3 | 3 |
Abbreviations: M, male; F, female; CTX, cefotaxime; CRO, ceftriaxone; LEVO, levofloxacin; VAN, vancomycin; RIFA, rifampin; ND, not done.